Outcome at 6 Months After Immunosuppressive Treatment
Parameter . | CSA . | ATG + CSA . | P . | ||
---|---|---|---|---|---|
No. . | % . | No. . | % . | ||
No. of patients | 61 | 54 | |||
Complete response | 14 | 23 | 31 | 57 | |
Partial response | 14 | 23 | 9 | 17 | |
Total response | 28 | 46 | 40 | 74 | .02 |
No response | 33 | 54 | 14 | 26 | |
Hemoglobin (g/dL) | |||||
Median | 9.7 | 11.8 | .03 | ||
Range | 4.2-14.9 | 2.5-15.0 | |||
Neutrophil count (×109/L) | |||||
Median | 1.5 | 1.4 | .4 | ||
Range | 0.5-9.6 | 0.3-24.0 | |||
Platelet count (×109/L) | |||||
Median | 29 | 84 | .005 | ||
Range | 3-182 | 5-216 | |||
Early death | 4 | 2 | |||
Second ATG before 6 months | 15 | 25 | 3 | 6 | |
Lost to follow-up study | 1 | 0 | |||
BMT | 3 | 5 | |||
Late death | 1 | 2 | |||
Alive failure-free | 41 | 67 | 49 | 90 | .001 |
Parameter . | CSA . | ATG + CSA . | P . | ||
---|---|---|---|---|---|
No. . | % . | No. . | % . | ||
No. of patients | 61 | 54 | |||
Complete response | 14 | 23 | 31 | 57 | |
Partial response | 14 | 23 | 9 | 17 | |
Total response | 28 | 46 | 40 | 74 | .02 |
No response | 33 | 54 | 14 | 26 | |
Hemoglobin (g/dL) | |||||
Median | 9.7 | 11.8 | .03 | ||
Range | 4.2-14.9 | 2.5-15.0 | |||
Neutrophil count (×109/L) | |||||
Median | 1.5 | 1.4 | .4 | ||
Range | 0.5-9.6 | 0.3-24.0 | |||
Platelet count (×109/L) | |||||
Median | 29 | 84 | .005 | ||
Range | 3-182 | 5-216 | |||
Early death | 4 | 2 | |||
Second ATG before 6 months | 15 | 25 | 3 | 6 | |
Lost to follow-up study | 1 | 0 | |||
BMT | 3 | 5 | |||
Late death | 1 | 2 | |||
Alive failure-free | 41 | 67 | 49 | 90 | .001 |